Signaling Pathways in NSCLC as a Predictor of Outcome and Response to Therapy

ISSN： 0341-2040

Source： Lung, Vol.182, Iss.3, 2004-08, pp. : 151-162

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Individual Variability of Response to Antiplatelet Therapy is an Important Determinant of Adverse Clinical Outcome

By Mangiacapra Fabio Barbato Emanuele

High Blood Pressure & Cardiovascular Prevention, Vol. 17, Iss. 3, 2010-09 ,pp. : 121-130

Adis International

Access to resources Recommend Favorite

Porphyria cutanea tarda as a Predictor of Poor Response to Interferon Alfa Therapy in Chronic Hepatitis C

By Fernández I. Castellano G. Salamanca R. E. de Colina F. Cámara A. Gómez de la Morán M. J. Muñoz R. Solís-Herruzo J. A.

Scandinavian Journal of Gastroenterology, Vol. 38, Iss. 3, 2003-01 ,pp. : 314-319

Informa Healthcare

Access to resources Recommend Favorite

Signaling Pathways in Cardiac Myocyte Hypertrophy

By Hefti M.A. Harder B.A. Eppenberger H.M. Schaub M.C.

Journal of Molecular and Cellular Cardiology, Vol. 29, Iss. 11, 1997-11 ,pp. : 2873-2892

Academic Press

Access to resources Recommend Favorite

Emerging Signaling Pathways in Hepatocellular Carcinoma

Liver Cancer, Vol. 1, Iss. 2, 2012-09 ,pp. : 83-93

Karger

Access to resources Recommend Favorite

Cause Is the Main Predictor of Outcome in Patients with Pontine Hemorrhage

Cerebrovascular Diseases, Vol. 17, Iss. 1, 2003-12 ,pp. : 66-71

Karger

Access to resources Recommend Favorite